Elaine Naughton provides healthcare regulatory counsel as it relates to compliance, operational and transactional matters.
Prior to joining Bass, Berry & Sims, Elaine served as a law clerk to the Honorable David J. Hale of the U.S. District Court for the Western District of Kentucky. Elaine earned her law degree from the University of Kentucky College of Law and a B.A. in history from the University of Chicago.
American Health Lawyers Association (AHLA)
We represented BioScrip, Inc. in its merger with Option Care Enterprises, Inc. The newly combined company, Option Care Health, Inc., emerges as the largest independent home and alternate site infusion services provider in the United States. Option Care Health’s common stock will be listed on the Nasdaq Global Select Market under the ticker symbol BIOS.
We represented HealthTrust (Healthtrust Purchasing Group, L.P.) in its definitive agreement to acquire Resource Optimization & Innovation (ROi), a recognized leader in healthcare supply chain management.
Represented Consonance Capital Partners in the recapitalization of Orsini Pharmaceutical Services, LLC
Represented American Physician Partners in its acquisition of Texas-based Emergigroup Physician Associates
Represented PhyMed Healthcare Group in its Partnership with Grand Canyon Anesthesia
Provided healthcare regulatory and antitrust counsel to Avella Specialty Pharmacy in its sale to OptumRx
Represented Addus HomeCare Corporation in its acquisition of Ambercare for $40 million.
Represented Medical Specialties Distributors (MSD) to McKesson Corporation.
Served as lead healthcare regulatory counsel to Ardent Health Services in its acquisition of East Texas Medical Center Regional Healthcare System (ETMC)
We represented Mainsail Partners in its $30 million growth equity investment in Bio-Optronics.
Kentucky Law Journal — Production Editor
CALI Awards — Healthcare Organizations & Finance; Federal Criminal Law; Criminal Law; Criminal Procedure; Conflict of Laws; Products Liability; and Torts